Literature DB >> 6603702

Prophylactic antimicrobial treatment in transurethral prostatectomy. How long should it be instituted?

B Goldwasser, B Bogokowsky, O Nativ, A A Sidi, P Jonas, M Many.   

Abstract

Eighty-one patients with proved preoperative sterile urine and undergoing transurethral resection of the prostate were studied. The patients were divided into 3 groups: group A received sulfamethoxazole-trimethoprim (ST) preoperatively and postoperatively for ten days; group B received ST in 2 divided doses, one pre- and one postoperatively; group C received no prophylaxis. In groups A and B, we found urinary infection in 3.8 per cent of patients compared with 32 per cent in group C. Performing prostatic chip cultures, we found that most urinary infections were unrelated to a prostatic source. When the prostate was infected, 75 per cent had infected urine postoperatively. We believe that prophylactic antimicrobial treatment should be given to all patients undergoing transurethral prostatectomy. However, it seems that immediate perioperative treatment suffices.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603702     DOI: 10.1016/0090-4295(83)90494-6

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  2 in total

1.  Controlled trial of a short and a prolonged course with ciprofloxacin in patients undergoing transurethral prostatic surgery.

Authors:  M Grabe; A Forsgren; T Björk; S Hellsten
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

2.  Prophylaxis in urological surgery.

Authors:  R A Janknegt
Journal:  Infection       Date:  1992       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.